Emerging as a promising candidate in the fight against malignancies, EPT Fumarate is gaining traction within the research community. This compounds possesses unique properties that disrupt key pathways within malignant growth, ultimately leading to inhibition of their proliferation. Studies have revealed encouraging outcomes in preclinical settings